Enzalutamide should be Enzalutamide and Abiraterone is Abiraterone Acetate, both are not recommended to be taken at the same time, and should be used in accordance with medical advice. Enzalutamide, commonly available in capsule form, is an androgen receptor inhibitor that inhibits prostate cancer cell proliferation and reduces tumor volume. It is used in the treatment of prostate cancer. Adverse effects of this product include fatigue, hot flashes, decreased appetite, dizziness, arthralgia, hypertension, headache, and weight loss. The drug is contraindicated in people with a history of allergy to the product and during pregnancy. Abiraterone acetate is an androgen biosynthesis inhibitor and this product is used in combination with prednisone, or prednisolone to treat prostate cancer. The drug is contraindicated in people with hypersensitivity reactions to the product, pregnancy, and severe hepatic impairment. Adverse reactions can be seen as hypertension, hypokalemia, fluid retention, peripheral edema, hypokalemia, and urinary tract infections. No studies have confirmed that enzalutamide works better in combination with abiraterone, and abiraterone needs to be used in combination with prednisone, while the instructions for enzalutamide state that drug interactions can occur between this product and corticosteroids such as prednisone. Therefore, simultaneous use is not recommended. The medication should be used appropriately under the guidance of a doctor.